Q32 Bio Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Q32 Bio Inc. (FIXX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $1.01 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2024-03-13
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2023-03-31 was $1.06, a 40.45% decline year-over-year.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2022-03-31 was $1.78, a 78.73% decline year-over-year.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2021-03-31 was $8.37, a 32.88% decline year-over-year.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2020-03-31 was $12.47, a 21.08% decline year-over-year.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $1.01, a 39.88% decline from fiscal 2022.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $1.68, a 76.86% decline from fiscal 2021.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2021 was $7.26, a 30.13% decline from fiscal 2020.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2020 was $10.39, a 19.46% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2023-12-31 | $1.01 10-K · filed 2024-03-13 | |||
| 2023-09-30 | $1.01 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $1.01 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $1.06 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $1.68 10-K · filed 2024-03-13 | |||
| 2022-09-30 | $1.72 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | $1.72 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $1.78 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $7.26 10-K · filed 2023-03-09 | |||
| 2021-09-30 | $7.50 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $7.77 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | $8.37 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $10.39 10-K · filed 2022-03-23 | |||
| 2020-09-30 | $10.73 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | $11.22 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $12.47 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $12.90 10-K · filed 2021-03-11 | |||
| 2019-09-30 | $14.70 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | $15.12 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | $15.80 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $10.41 10-K · filed 2020-03-12 | |||
| 2018-09-30 | $8.51 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $8.38 10-Q · filed 2019-08-08 | |||
| 2018-03-31 | $8.44 10-Q · filed 2019-05-13 | |||
| 2017-12-31 | $2.78 10-K · filed 2019-03-12 | |||
| 2017-09-30 | $1.19 10-Q · filed 2018-11-13 | |||
| 2017-06-30 | $0.33 10-Q · filed 2018-08-13 | |||
| 2017-03-31 | $0.34 10-Q · filed 2018-05-14 |